Cell-Freezing Devices Are Not Strictly Needed to Start an Autologous Hematopoietic Transplantation Program: Non-Cryopreserved Peripheral Blood Stem Cells Can be Used to Restore Hematopoiesis after High Dose Chemotherapy: A Multicenter Experience in 268 Autografts in Patients with Multiple Myeloma or Lymphoma. Study on Behalf of the Latin-American Bone Marrow Transplantation Group (LABMT)Amado Karduss, Juan Alejo Jimenez, Guillermo J. Ruíz‐Argüelles et al.|Blood|2014Cited by 16
Intensification of the Regimen Fludarabine Melphalan with the Addition of 400 Cgy of Total Body Irradiation in Allogeneic Stem Cell Transplantation. It Is Feasible, Has a Good Anti-Leukemic Effect and a Low ToxicityAmado Karduss, Pedro Reyes, Rosendo Lurı́a-Pérez et al.|Blood|2015Cited by 1
Long Term Follow up of Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide in Children and Teenagers < 18 Years Old with High-Risk Acute Leukemia. Very Good Results in CR1 and CR2 Patients but Unexpected High Incidence of Severe Acute Graft Versus Host Disease in Children < 10 YearsÁngela Maria Trujillo, Luis Rodolfo Manosalvas Gómez, Amado Karduss et al.|Blood|2017Cited by 1
Abstract C82: Carboplatin replacing BCNU in the BCNU, etoposide, cyclophosphamide (CVP) regimen for autologous stem cell transplant in patients with advanced lymphoma. Very low toxicity and encouraging resultsMiguel González Vélez, Clara Fernandez, Amado Jose Karduss-Urueta et al.|Cancer Epidemiology Biomarkers & Prevention|2016Cited by 0
Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide Using As Conditioning Fludarabine Melphalan Plus 200-400cGy of Total Body Irradiation. Very Good Balance Between Tolerance and Anti Leukemic ActivityAmado Karduss, Angélica Cardona, Rosendo Lurı́a-Pérez et al.|Blood|2016Cited by 0